Polygenic in vivovalidation of cancer mutations using transposons
Su Kit Chew(Wellcome Sanger Institute), P. Andrew Futreal(Wellcome Sanger Institute), Adam Collinson(Babraham Institute), Juexuan Wang(Wellcome Sanger Institute), David Jones(European Bioinformatics Institute), John Gamble(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Abdel Saci(Harvard University), Jonathan Hinton(Wellcome Sanger Institute), Dong Lu(Baylor College of Medicine), Lia S. Campos(Universidade Federal de Minas Gerais), Stuart McLaren(European Bioinformatics Institute), Sarah O’Meara(Wellcome Sanger Institute), Lynda Chin(American Productivity and Quality Center), Jon W. Teague(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Keiran Raine(Wellcome Sanger Institute), Kenneth L. Scott(Dana-Farber Cancer Institute), Pentao Liu(Hong Kong Science and Technology Parks Corporation)
Cited by 6
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k